The next episode (an interview with a scientific expert discussing ePPP research and ethical considerations) is erring with Spotify, so find it on YouTube on Monday morning!

https://youtube.com/@TheVitalsPodcast

Sources:

W.H.O. Authorizes Mpox Vaccine, Clearing Way for Use in Africa - The New York Times (nytimes.com)

CDC says mpox vaccine boosters aren’t needed in the US as questions emerge around waning immunity | CNN

Morocco Reports First Mpox Case (usnews.com)

Mpox outbreak: Morocco confirms first case in current outbreak (bbc.com)

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

Goodpods: @cjtaylor

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Sources:

This Mpox Outbreak Isn't Like the Last One | WIRED

Mpox (who.int)

UNICEF issues emergency tender to secure mpox vaccines for crisis-hit countries in collaboration with Africa CDC, Gavi and WHO

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

Goodpods: @cjtaylor

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Sources:

Youth with conduct disorder show widespread differences in brain structure | National Institutes of Health (NIH)

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

Goodpods: @cjtaylor

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Our first story comes from Dr. Steven A. Rosenberg and other NIH researchers who are studying immunotherapy’s effectiveness against solid tumors. Our second story comes from Dr. Richard Krauzlis and other NIH researchers at the NIH’s National Eye Institute, who have discovered a new circuit in brains that helps us recognize faces.

Goodpods Show!

The Vitals Podcast

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

Goodpods: @cjtaylor

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Sources:

Immunotherapy approach shows potential in some people with metastatic solid tumors | National Institutes of Health (NIH)

Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results | Nature Medicine

NIH researchers discover a new face-detecting brain circuit | National Institutes of Health (NIH)

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Sources:

https://www.chaunceytaylor.com/a-healing-evolution/

Our first story comes from Dr. Ami Shah and other experts at Stanford Medicine Children’s Health, where trials were conducted for a new gene therapy to treat X-linked ALD. Our second story comes from Dr. Wyndham H. Wilson and Dr. Christopher Melani and their team of researchers at the National Institutes of Health, who have developed a non-chemotherapy treatment regimen for people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments.

Discord Server!!!

https://discord.gg/Mx6uBeqc

Follow me!

IG: @chaunceyjtaylor

Twitter/X: @chaunceyjtaylor

Medium: @chaunceyjtaylor

My YT: @C.J.Taylor

My Blog: chaunceytaylor.com

Need math tutoring? Book a session with me! https://tprs.co/fz9p1

Sources:

Stanford Medicine offers gene therapy for a devastating pediatric neurologic disease | News Center | Stanford Medicine

Elivaldogene Autotemcel: First Approval - PubMed (nih.gov)

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma | New England Journal of Medicine (nejm.org)

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma | National Institutes of Health (NIH)